Jungle Deals Blog

The best Amazon deals! And the most Amazon deals!

Low Price on Amazon Basic Care Ibuprofen Tablets 200 mg, Pain Reliever/Fever Reducer (NSAID), 500 Count

** Note: Deal has sold out -- below are some of the most popular ways to keep in touch so you don't miss future HOT deals like this one. **

Purchase Amazon Basic Care Ibuprofen Tablets 200 mg, Pain Reliever/Fever Reducer (NSAID), 500 Count at Amazon.com

Better to have them than not! Hop on over to Amazon where you can score a fantastic price on the Amazon Basic Care Ibuprofen Tablets 200 mg, Pain Reliever/Fever Reducer (NSAID), 500 Count now down to $9.11 (reg. $14.59). Get up to extra 15% off when you use the Subscribe & Save checkout method lowering the price to as low as $7.74 shipped!

Purchase Amazon Basic Care Ibuprofen Tablets 200 mg, Pain Reliever/Fever Reducer (NSAID), 500 Count on Amazon.com

  • ACTIVE INGREDIENT: This product contains ibuprofen 200 mg, a pain reliever and fever reducer (NSAID); compare to the active ingredient in Advil Ibuprofen Tablets
  • PAIN RELIEVER AND FEVER REDUCER: Proven pain relief without a prescription for tough pain such as muscular aches, minor arthritis pain, toothache, backache, menstrual cramps or minor aches and pains from the common cold; also temporarily reduces fever
  • STRONG RELIEF: Amazon Basic Care Ibuprofen Tablets 200 mg are strong on tough pain to help you get the relief you need to keep going; no prescription needed for this pain reliever and fever reducer
  • EFFECTIVE: When pain tries to take over, turn to the proven pain relief of coated Amazon Basic Care Ibuprofen Tablets 200 mg; use for adults and children 12 years and over
  • IBUPROFEN is the number one doctor recommended back pain OTC active ingredient (of U.S. physicians surveyed by an independent market research firm)

See it here: Amazon Basic Care Ibuprofen Tablets 200 mg, Pain Reliever/Fever Reducer (NSAID), 500 Count >>>

You may also want to look at...

Details. This post may contain affiliate links which support this site. Read our disclosure policy here.

Comments are currently closed.